These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23067780)

  • 1. Use of the PRIMUS scale to assess quality of life in a Spanish population of multiple sclerosis patients.
    Hernández MA; Mora S;
    Neurologia; 2013; 28(6):340-7. PubMed ID: 23067780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of depression, disability, and family caregiver attitudes to the quality of life of Kuwaiti persons with multiple sclerosis: a controlled study.
    Alshubaili AF; Awadalla AW; Ohaeri JU; Mabrouk AA
    BMC Neurol; 2007 Sep; 7():31. PubMed ID: 17877820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and quality of life of multiple sclerosis in Spain.
    Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA;
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
    Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between spasticity and quality of life in patients with multiple sclerosis: the CANDLE study.
    Arroyo R; Massana M; Vila C
    Int J Neurosci; 2013 Dec; 123(12):850-8. PubMed ID: 23819835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
    Wynia K; van Wijlen AT; Middel B; Reijneveld SA; Meilof JF
    Mult Scler; 2012 May; 18(5):654-61. PubMed ID: 21965423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in Polish patients with multiple sclerosis.
    Mitosek-Szewczyk K; Kułakowska A; Bartosik-Psujek H; Hożejowski R; Drozdowski W; Stelmasiak Z
    Adv Med Sci; 2014 Mar; 59(1):34-8. PubMed ID: 24797971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between quality of life and dysarthria in patients with multiple sclerosis.
    Piacentini V; Mauri I; Cattaneo D; Gilardone M; Montesano A; Schindler A
    Arch Phys Med Rehabil; 2014 Nov; 95(11):2047-54. PubMed ID: 24835754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living.
    Kamm CP; Heldner MR; Vanbellingen T; Mattle HP; Müri R; Bohlhalter S
    Arch Phys Med Rehabil; 2012 Jun; 93(6):1081-5. PubMed ID: 22464095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires.
    Fernández O; Baumstarck-Barrau K; Simeoni MC; Auquier P;
    Mult Scler; 2011 Oct; 17(10):1238-49. PubMed ID: 21669936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
    Arch Neurol; 2004 May; 61(5):679-86. PubMed ID: 15148144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study.
    Patti F; Russo P; Pappalardo A; Macchia F; Civalleri L; Paolillo A;
    J Neurol Sci; 2007 Jan; 252(2):121-9. PubMed ID: 17188301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and quality of life of multiple sclerosis in Germany.
    Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
    Saiz A; Mora S; Blanco J;
    Neurologia; 2015 May; 30(4):214-22. PubMed ID: 24484756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life of multiple sclerosis in Austria.
    Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [French validation of the Multiple Sclerosis International Quality of Life Questionnaire].
    Baumstarck-Barrau K; Pelletier J; Simeoni MC; Auquier P;
    Rev Neurol (Paris); 2011; 167(6-7):511-21. PubMed ID: 21420136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.